معرفی
Mohamed Elsawy is a Senior Lecturer in Pharmaceutical Sciences at the Leicester School of Pharmacy, De Montfort University, within the Faculty of Health and Life Sciences. He leads the Peptide BioNanomaterials Group (PBNG) and is actively involved in research, teaching, and postgraduate supervision. His work bridges pharmaceutical innovation with advanced biomaterials development.
Education:
- PhD in Pharmacy (Medicinal Chemistry), Queen’s University Belfast, 2012
- Graduate Diploma in Pharmaceutical Chemistry, Cairo University, 2007
- BPharmSc, Cairo University, 2004
Mohamed's research centers on peptide self-assembly into functional nanostructures for biomedical applications. His expertise includes designing ultra-short ionic peptides that form β-sheet nanofibers and hydrogels for drug delivery, tissue engineering, and 3D bioprinting. His work emphasizes biocompatibility, stimuli-responsiveness, and nanoscale tunability. Applications span anticancer therapy, stem cell encapsulation, and antimicrobial hydrogels to combat resistance.
His recent publications highlight a strong trend in peptide-based bionanomaterials, with focus on self-assembly mechanisms, hydrogel design, and therapeutic delivery systems. Work spans from fundamental molecular interactions to translational applications in oncology, inflammation, and metabolic diseases.
Scientific Recognition:
- Fellow of the Higher Education Academy (FHEA)
- Member of the Royal Society of Chemistry (MRSC)
- Member of UK and European Societies of Biomaterials
Mohamed has supervised multiple PhD, MSc, and MRes students, both as primary and secondary supervisor. He has secured significant research funding as Principal Investigator, including a £156K Newton Fund grant and a £150K Mission’s Sector Egyptian Fund award. He serves as a peer reviewer for UK and European research councils and scientific journals. His research group, PBNG, is affiliated with the Leicester Institute of Pharmaceutical Innovation for Integrated Care (LIPIIC), contributing to collaborative pharmaceutical innovation.
Research Infrastructure: The Peptide BioNanomaterials Group (PBNG) operates within LIPIIC, focusing on interdisciplinary development of peptide-based delivery systems and biomaterials. The team integrates synthesis, characterization, and application testing for translational outcomes.
